Search clinical trials for: Restenosis,

Total 417 results

Seoul National University Hospital

Unknown

Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -

In-stent Restenosis Lesion

Korea, Republic of
Ospedale Santa Maria Goretti

Withdrawn

Prognostic Assessment of Different Pattern of Bifurcation Restenosis (LATINA)

In-stent Coronary Artery Restenosis

Italy
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)

In-Stent Restenosis

Spain
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
University College London Hospitals
UCL/UCLH Clinical Research and Development Fund

Unknown

The Safety and Efficacy of Photodynamic Therapy for Femoral Artery Stenosis

Atherosclerotic Narrowing of the Superficial Femoral Artery | Atherosclerotic Occlusion of the Superficial Femoral Artery

United Kingdom
Midwest Cardiovascular Research Foundation

Completed

JetStream Atherectomy for the Treatment of In-stent Restenosis (JET-ISR)

Femoropopliteal In-stent Restenosis

United States
Spectranetics Corporation
Yale University

Withdrawn

First in Human Study of Winsor Laser Catheter: A Prospective Registry to Evaluate The Safety and Performance of the Winsor Laser Catheter in the Treatment of In-Stent Restenosis

Femoropopliteal In-Stent Restenosis

Colombia
Boston Scientific Corporation

Active, not recruiting

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) (AGENT IDE)

In-Stent Restenosis

United States
Klinikum Coburg

Unknown

Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

In-Stent Restenosis

Germany
Medical University of Warsaw
KCRI

Unknown

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (ISRII)

In-Stent Restenosis

Poland
Assiut University

Not yet recruiting

Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention

In-stent Restenosis
Luzerner Kantonsspital

Unknown

Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis

In-stent Restenosis
Spanish Society of Cardiology
Abbott Medical Devices; Fundación de Investigación Biomédica - Hospital Universitario... and other collaborators

Unknown

Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis (RIBS VII)

Coronary In-stnent Restenosis

Spain
Genoss Co., Ltd.

Completed

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patient With Coronary In-stent Restenosis

Coronary Artery Disease
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan
University Hospital Ostrava

Recruiting

Carotid Endarterectomy vs. Repeated Carotid Angioplasty and Stenting for In-Stent Restenosis (CERCAS)

In-Stent Carotid Artery Restenosis

Czechia
Celgene

Completed

A Safety Study of ABI-007 for In-Stent Restenosis

Coronary Artery Disease | Angina Pectoris

United States
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
ReFlow Medical, Inc.

Not yet recruiting

A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)

In-stent Restenosis
Yonsei University

Recruiting

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR) (GENISPIRE)

In-stent Restenosis

Korea, Republic of
University Hospital, Clermont-Ferrand
Abbott; Corelab ISIT

Completed

Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT (RESTO)

In-stent Restenosis

France, Belgium, Switzerland
Chansu Vascular Technologies

Active, not recruiting

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

In-stent Restenosis

Spain, France, Georgia, Lithuania
RenJi Hospital

Completed

In-stent Restenosis and Pericoronary Fat Attenuation Index

In-stent Restenosis

China
Shandong Branden Med.Device Co.,Ltd
Fudan University

Unknown

Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter

In-stent Restenosis

China
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Fu Wai Hospital, Beijing, China

Not yet recruiting

Anti-inflammatory Therapy for Recurrent In-stent Restenosis

In-stent Restenosis

China
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
C. R. Bard

Completed

PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis (PERVIDEO I)

In-Stent Restenosis

Netherlands, Belgium, Germany
Celgene Corporation

Completed

Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis (SNAPIST-III)

Coronary Restenosis
Genoss Co., Ltd.

Active, not recruiting

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Chinese Patients With Coronary ISR

Coronary Artery Disease

China
Beijing Anzhen Hospital

Unknown

Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis

Percutaneous Coronary Intervention

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
B. Braun Medical B.V.

Unknown

DARE-trial: A Trial Studying the Effect of the SeQuent Please Drug-eluting Balloon Compared to the Xience Prime Drug-eluting Stent for the Treatment of Stenosis of an Earlier Implanted Stent.

In-stent Restenosis

Netherlands
Jinling Hospital, China
CSPC-NBP Pharmaceutical Co., Ltd.

Completed

Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting (BPRIAS)

Restenosis

China
Centre Hospitalier Universitaire, Amiens

Withdrawn

Search for Restenosis Markers in Lower Limb Arteritis (FEMIA)

Restenosis | Lower Limb Arteritis

France
VIVA Physicians
W.L.Gore & Associates; Spectranetics Corporation

Terminated

Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis (SALVAGE)

Restenosis

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Kobe City General Hospital
Osaka University; Okayama University; Kobe University; Nagoya University; Kyoto University and other collaborators

Completed

Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE)

In-stent Restenosis After Carotid Artery Stenting

Japan
Yanbin Li

Not yet recruiting

Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

Stent Restenosis
B. Braun Medical International Trading Company...

Completed

A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent (PEPCAD)

Coronary Instent Restenosis

China
Sarepta Therapeutics, Inc.

Terminated

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

Coronary Artery Disease | Coronary Stent Restenosis
C. R. Bard

Completed

FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis (RESCUE)

Restenosis

United States
Herz-Zentrums Bad Krozingen

Unknown

Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions (PHOTOPAC)

Restenosis
Silesian Centre for Heart Diseases

Unknown

Metal Allergy In-Stent Restenosis Study (RESTALL)

Coronary Artery Disease | Restenoses, Coronary | In-stent Restenosis | Contact Allergy | Metal Allergy
Semmelweis University Heart and Vascular Center

Recruiting

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis (OPEN-ISR)

Coronary Stent Restenosis

Hungary
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genomics of In-Stent Restenosis

In-Stent Restenosis | Vascular Disease

United States
Lin Zhao

Recruiting

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

In-stent Restenosis | Major Adverse Cardiovascular Events

China
Spanish Society of Cardiology
Abbott Medical Devices; Terumo Medical Corporation; Fundación de Investigación... and other collaborators

Unknown

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) (RIBS VI)

Coronary In-stent Restenosis

Spain
B. Braun Medical Inc.
Infraredx; Bright Research Partners

Withdrawn

Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment (RESPECT-ISR)

Coronary Artery Restenosis | In-stent Restenosis | In-stent Coronary Artery Restenosis
Medstar Health Research Institute

Withdrawn

REWARDS- In-stent Restenosis

In-Stent Coronary Artery Restenosis

United States
Medstar Health Research Institute

Unknown

Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation

In-stent Coronary Artery Restenosis

United States

Search clinical trials for: Restenosis,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations